J Cancer
2014; 5(1):69-78.
doi:10.7150/jca.7048 This issueCite
Review
Future Directions for Monitoring Treatment Responses in Breast Cancer
Matthew P. Shupe1✉, Lindsey J. Graham1, Erika J. Schneble2, Frederick L. Flynt1, Michael N. Clemenshaw3, Aaron D. Kirkpatrick4, Alexander Stojadinovic5, George E. Peoples6, Nathan M. Shumway1
1. Department of Hematology/Oncology 2. Department of Surgery 3. Department of Nuclear Medicine 4. Department of Diagnostic Radiology 5. Department of Surgical Oncology, San Antonio Military Medical Center (SAMMC), Brooke Army Medical Center, 3551 Roger Brooke Dr., Ft. Sam Houston, TX 78234, USA 6. Department of Surgical Oncology, Walter Reid National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA
✉ Corresponding author: Matthew P. Shupe, Brooke Army Medical Center, Department of Hematology/Oncology, 3551 Roger Brooke Dr., Ft. Sam Houston, TX 78234. Office: 210-916-0751; Fax: 210-916-3366; Email: matthew.p.shupe.milmil; mattshupecomMore
Citation:
Shupe MP, Graham LJ, Schneble EJ, Flynt FL, Clemenshaw MN, Kirkpatrick AD, Stojadinovic A, Peoples GE, Shumway NM. Future Directions for Monitoring Treatment Responses in Breast Cancer. J Cancer 2014; 5(1):69-78. doi:10.7150/jca.7048. https://www.jcancer.org/v05p0069.htm
In the prior review, we outlined the current standard of care for monitoring treatment responses in breast cancer and discussed the many challenges associated with these strategies. We described the challenges faced in common clinical settings such as the adjuvant setting, neoadjuvant setting, and the metastatic setting. In this review, we will expand upon future directions meant to overcome several of these current challenges. We will also explore several new and promising methods under investigation to enhance how we monitor treatment responses in breast cancer. Furthermore, we will highlight several new technologies and techniques for monitoring breast cancer treatment in the adjuvant, neoadjuvant and metastatic setting.
Keywords: breast cancer, treatment monitoring, future directions, adjuvant, neoadjuvant, metastatic
Citation styles
APA
Shupe, M.P., Graham, L.J., Schneble, E.J., Flynt, F.L., Clemenshaw, M.N., Kirkpatrick, A.D., Stojadinovic, A., Peoples, G.E., Shumway, N.M. (2014). Future Directions for Monitoring Treatment Responses in Breast Cancer. Journal of Cancer, 5(1), 69-78. https://doi.org/10.7150/jca.7048.
ACS
Shupe, M.P.; Graham, L.J.; Schneble, E.J.; Flynt, F.L.; Clemenshaw, M.N.; Kirkpatrick, A.D.; Stojadinovic, A.; Peoples, G.E.; Shumway, N.M. Future Directions for Monitoring Treatment Responses in Breast Cancer. J. Cancer 2014, 5 (1), 69-78. DOI: 10.7150/jca.7048.
NLM
Shupe MP, Graham LJ, Schneble EJ, Flynt FL, Clemenshaw MN, Kirkpatrick AD, Stojadinovic A, Peoples GE, Shumway NM. Future Directions for Monitoring Treatment Responses in Breast Cancer. J Cancer 2014; 5(1):69-78. doi:10.7150/jca.7048. https://www.jcancer.org/v05p0069.htm
CSE
Shupe MP, Graham LJ, Schneble EJ, Flynt FL, Clemenshaw MN, Kirkpatrick AD, Stojadinovic A, Peoples GE, Shumway NM. 2014. Future Directions for Monitoring Treatment Responses in Breast Cancer. J Cancer. 5(1):69-78.